Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

20 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Perflutren Lipid Microsphere Articles

FDA orders label safety warnings for echocardiogram imaging agents

15 October 2007

Point Bio starts Ph III trial of contrast agent

19 August 2002

Sonus refocuses operations as ultrasound contrast agent flounders

17 October 2000

DuPont spending spree continues with acquisition of ImaRx Pharmaceutical

12 October 1999

DuPont's Definity filed in EU

23 September 1999

DuPont Files For Ultrasound Agent

16 December 1998

Showing 1-6 of 6 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Elan makes "transformational" acquisitions and a divestment
  • Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
  • New study shows UCB's Neupro reduces NSBP in RLS patient
  • Bristol-Myers' data on Yervoy and nivolumab causes a stir
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
  • New study shows UCB's Neupro reduces NSBP in RLS patient
  • Bristol-Myers' data on Yervoy and nivolumab causes a stir
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS